The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhou, P.
Right arrow Articles by Seder, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhou, P.
Right arrow Articles by Seder, R. A.
The Journal of Immunology, 2001, 166: 1968-1974.
Copyright © 2001 by The American Association of Immunologists

Perforin Is Required for Primary Immunity to Histoplasma capsulatum

Ping Zhou*, Brenda L. Freidag*, Charles C. Caldwell{dagger} and Robert A. Seder1,*

* Clinical Immunology Section, Laboratory of Clinical Investigation, and {dagger} Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Protective immunity against primary and secondary infection by the fungus Histoplasma capsulatum (HC) is multifactorial, requiring cells of the innate and adaptive immune response. Effector mechanisms that could mediate intracellular killing of HC include cytokines such as IFN-{gamma} and TNF-{alpha} and/or direct cytolytic activity by T and NK cells. In this regard, although previous work has clearly demonstrated a critical role for IFN-{gamma} and TNF-{alpha} in limiting fungal growth in primary HC infection, less is known regarding the role of cytolytic mechanisms. The studies reported here first address the role of perforin in mediating immunity to HC. Remarkably, perforin-deficient knockout (PfKO) mice were shown to have accelerated mortality and increased fungal burden following a lethal or sublethal primary challenge. These data established an essential role for perforin in primary immunity systemic HC infection. Interestingly, depletion of CD8+ T cells in PfKO mice caused a further increase in fungal burden and accelerated mortality, suggesting a perforin-independent role for CD8+ T cells. Moreover, adoptive transfer of CD8+ T cells from PfKO mice into IFN-{gamma}-/- mice caused a reduction in fungal burden following infectious challenge compared with control IFN-{gamma}-/- mice. Together, these data suggest that CD8+ T cells can mediate immunity to HC through both perforin-dependent and -independent mechanisms.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Histoplasma capsulatum (HC)2 is a dimorphic fungus found in the soil in the midwestern and southern regions of the United States. Primary infection occurs through inhalation of conidial or mycelial fragments, which in immunocompetent hosts results in a self-limited upper respiratory infection involving only the lungs. Moreover, in most instances long-lasting protective immunity is sustained following primary infection. In contrast to primary pulmonary infection, disseminated infection can occur in immunocompromised hosts in multiple organs through either reactivation of a previous infection or primary exposure (1). Over the past 10–15 years, there has been an increase in the number of reports of disseminated histoplasmosis, most notably in individuals infected with HIV (2). These data strongly suggest that the cellular immune response has a critical role in the maintenance of effective immunity to HC.

The mechanism by which the cellular immune response is able to control infection by a variety of intracellular pathogens has been an area of intense interest. This process involves an interaction between the innate and acquired immune responses and involves both cytokine-dependent and -independent mechanisms. First, with regard to cytokine-dependent mechanisms, IL-12-dependent production of IFN-{gamma} has been shown to be critical for protection following primary infection in bacterial (Listeria monocytogenes) (3), fungal (HC) (4, 5), and parasitic (Leishmania major) (6) murine models. In addition, for HC (7, 8) as well as other pathogens, TNF-{alpha} has also been shown to have an essential effector role for control of infection. The ordered sequence of these cytokine responses has been modeled for many of the aforementioned intracellular infections. First, macrophages and/or dendritic cells are infected, process Ag, and then release cytokines, which include IL-12 and TNF-{alpha}. IL-12 can then induce production of IFN-{gamma} from cells expressing a functional IL-12 receptor, such as NK cells, leading to the release of IFN-{gamma}. This early sequence of events characterizes part of the innate immune response. Subsequently, cells of the acquired immune response (CD4+ and CD8+ T cells) become activated and provide additional immunity sufficient to substantially eradicate the infection and maintain immune memory.

The importance of T cells in HC infection has been clearly demonstrated by several findings. First, nude or SCID mice are more susceptible to systemic infection with HC (9, 10). In addition, depletion of {alpha}{beta} T cells in naive mice leads to increased fungal burden and accelerated mortality in both primary and secondary infection (8). Furthermore, studies have delineated the role of specific types of T cells following pulmonary or systemic HC infection. With regard to systemic infection, depletion of CD4+ T cells in naive mice at the time of infection resulted in accelerated mortality (8, 11). By contrast, systemic infection either of naive mice depleted of CD8+ T cells at the time of infection or of {beta}2-microglobulin-deficient ({beta}2m-/-) mice did not result in a fatal outcome. However, these mice did have an increased fungal burden when compared with controls (12). In the pulmonary model of HC infection, naive mice depleted of CD4+ T cells had a marked decrease in production of IFN-{gamma} correlating with the accelerated mortality in these mice (8). In this same study, mice treated with anti-CD8 had impaired clearance of HC; however, production of IFN-{gamma} was not appreciably changed compared with that of control mice. These data suggest that CD8+ T cells could have a role in controlling primary pulmonary infection independent of IFN-{gamma}. This is consistent with our previous report showing that, following secondary infection via the i.v. route, control of fungal growth can be sustained in the absence of IFN-{gamma} but is dependent on either CD4+ or CD8+ T cells (7). Together, these data clearly demonstrate that an IFN-{gamma}-independent mechanism exists for control of HC infection and is dependent on CD4+ or CD8+ T cells.

The focus of this study was to determine cytokine-dependent and -independent mechanisms by which T cells mediate immunity to HC infection. In this report, we show that perforin has an essential role in primary immunity to systemic HC infection. In addition, CD8+ T cells are shown to mediate control of HC infection in a perforin-independent manner. Data are also presented that suggest that this latter pathway is mediated by IFN-{gamma}. Together, these data provide new evidence for a critical role of perforin in primary immunity to HC, furthering our understanding of the multifactorial manner in which primary immunity to HC is controlled by T cells.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Mice and infection

Perforin-deficient knockout (PfKO) mice derived using a C57BL/6 embryonic stem cell line were purchased from The Jackson Laboratory (Bar Harbor, ME). In the experiments, C57BL/6 mice obtained from either The Jackson Laboratory or the National Cancer Institute were used with identical results. IFN-{gamma}-/-, MHC class II-deficient, and {beta}2m-/- mice that were homozygous on the C57BL/6 background were purchased from Taconic Farms (Germantown, NY). All mice were kept in the National Institute of Allergy and Infectious Diseases Animal Care Facility under pathogen-free conditions. Mice used were between 6 and 10 wk of age. For primary infection, mice were inoculated i.v. in 0.5-ml sterile PBS with either a lethal (6 x 105) or sublethal (6 x 104) dose of HC yeast cells. In experiments studying secondary immunity, mice were initially immunized i.v. with a sublethal dose (6 x 104 or 1 x 104) of HC and then challenged with a lethal dose (6 x 105) of HC 3 wk later.

Media

HBSS and PBS (BioFluids, Rockville, MD) were used as wash media. Complete medium was used for culturing spleen cells: RPMI 1640 (BioFluids) supplemented with 10% FCS (BioFluids), penicillin (100 U/ml), streptomycin (100 µg/ml), L-glutamine (2 mM), sodium pyruvate (1 mM), and 2-ME (0.05 mM).

Preparation and quantitation of HC

Yeast-phase HC (strain GS-57) was used for infection in all experiments as previously described (4). Quantitation of HC was performed as previously described (4). Briefly, three individual mice infected with HC and/or treated with different Abs were sacrificed at various times postinfection. Spleens were then homogenized in a sterile mortar using PBS to prepare a 1:10 weight:volume suspension. The serial 10-fold dilutions in PBS were plated in duplicate at 0.05 ml/plate on brain-heart infusion (BHI)-supplemented albumin growth factor chloramphenicol medium and incubated for 7 days at 30°C. Colonies were enumerated and the counts recorded as CFU. BHI-supplemented albumin growth factor chloramphenicol agar plates contained 37 g/L BHI, 15 g/L Bacto-Agar (Difco Laboratories, Detroit, MI), 0.1% BSA (Sigma, St. Louis, MO), 0.01% chloramphenicol, and 1% (v/v) growth factor prepared by Dr. R. P. Tewari (Department of Medical Microbiology and Immunology, Southern Illinois Medical School, Springfield, IL). Statistical analysis is described below.

In vivo treatment of mice

Purified rat anti-mouse IFN-{gamma} mAb (XMG1.2), anti-TNF-{alpha} (XT22), and anti-CD8 (2.43) were used to neutralize IFN-{gamma}, neutralize TNF-{alpha}, and deplete CD8+ T cells, respectively. Mice were treated with a single injection of anti-IFN-{gamma} (1 mg) or anti-TNF-{alpha} (1 mg) i.p. at the time of primary infection. For T cell depletion, anti-CD8 Ab were injected 3 days before, at the time of, and 3 days postinfection. This treatment resulted in a >95% depletion of CD8+ T cells from spleens at 1 wk after infection as assessed by FACS analysis (BD Biosciences, San Jose, CA).

Adoptive transfer experiment

Donor cells were harvested from spleens of PfKO mice or C57BL/6 mice that had been infected with a sublethal dose of HC yeast cells (1 x 104) 3 wk before transfer. CD8+ T cells were then isolated by positive selection using MACS CD8a (Lyt-2) beads from Miltenyi Biotec (Bergisch Gladbach, Germany). The purity of CD8+ T cells was >90% as assessed by FACS analysis. A total of 3 x 106 CD8+ T cells in 0.5 ml PBS were adoptively transferred i.v. into naive IFN-{gamma}-/- mice. After 2 h, IFN-{gamma}-/- mice were infected with 3 x 104 HC yeast cells.

Measurement of NK cell functional activity

51Cr release assays were performed as previously described (13). Briefly, yeast artificial chromosome (YAC)-1 lymphoma target cells were incubated for 1 h with 500 µCi of Na51CrO4 (Amersham, Arlington Heights, IL), followed by extensive washing twice in HBSS medium. The target cells were resuspended and added in place of effector cells in 96-well round plates. The effector cells were obtained at various time points from the spleens of three individual normal C57BL/6 or PfKO mice infected with HC. As a control, spleen cells from uninfected normal C57BL/6 and PfKO mice were also used in parallel. E:T ratios of 100:1, 50:1, 25:1, 12.5:1, and 6.25:1 were used in a total volume of 150 µl. Plates were incubated for 4 h at 37°C in a 5% CO2 incubator. Chromium release into the supernatants was determined with a gamma counter (Beckman Instruments, Palo Alto, CA). Specific 51Cr release was determined as follows: maximum chromium release and spontaneous release were calculated from wells incubated with 20 µl of 10% SDS (Sigma, St. Louis, MO) or medium alone, respectively. The percentage of specific release of 51Cr was calculated by the formula: % = [(experimental release - spontaneous release)/(maximum release - spontaneous release)] x 100%.

Statistics

For quantitation of fungal burden, statistical evaluation of differences between the means of experimental groups was done by ANOVA and with a multiple Student’s t test. The log rank was used for statistical analysis of mortality. A value of p < 0.05 was considered significant.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
CD4+ and CD8+ T cells have a critical role in primary immunity to HC

Previous work has established a central role for IL-12-dependent production of IFN-{gamma} in primary immunity against HC (4, 5), similar to many other intracellular infections. In addition, it has been shown that IFN-{gamma}-independent cytolytic mechanisms can also mediate a protective response against other intracellular pathogens such as L. monocytogenes (14). Our goal was to elucidate additional mechanisms of immunity to HC, focusing on the role of cytokine-independent, cytolytic pathways. In this regard, the first experiments established the role of CD4+ and CD8+ T cells in a systemic model of disseminated histoplasmosis. As shown in Fig. 1Go, MHC class II-/- or {beta}2m-/- mice had accelerated mortality compared with infected wild-type mice. The accelerated mortality correlated with increased fungal burden from spleens of these mice taken 6 days postinfection (data not shown). In addition, similar data were obtained from mice treated with anti-CD4, anti-CD8, or both. Together, these data suggest a role for both CD4+ and CD8+ T cells in primary systemic infection by HC.



View larger version (19K):
[in this window]
[in a new window]
 
FIGURE 1. MHC class I- and class II-restricted cells have a critical role in primary immunity to HC. MHC class II-/- or {beta}2m-/- (n = 4–6 per group) or wild-type C57BL/6 mice were injected i.v. with 6 x 105 yeast cells as described in Materials and Methods. There was a statistically significant difference (p < 0.001) in the mortality rate in MHC class II-/- or {beta}2m-/- mice compared with wild-type mice. The data were combined from three independent experiments.

 
CD4+ and CD8+ T cells are required for secondary immunity to HC

As an extension to the data shown above, the role of CD4+ and CD8+ T cells following secondary infection was also assessed using MHC class II- and {beta}2m-deficient mice, respectively (Fig. 2Go). In these experiments, C57BL/6, MHC class II-, or {beta}2m-deficient mice were initially infected with a sublethal dose of HC (6 x 104) and then reinfected with a lethal dose (6 x 105) 3 wk later. It should be noted that at the time of reinfection similar amounts of HC (~103 CFU) were detected from the spleens from C57BL/6, MHC class II-/-, or {beta}2m-/- mice (data not shown). As shown in Fig. 2Go, MHC class II-/- or {beta}2m-/- mice initially infected with a sublethal dose of HC survived secondary infection following a lethal challenge. In similar experiments, mice depleted of either CD4+ or CD8+ T cells at the time of secondary infection also survived a lethal challenge with HC (data not shown). These data suggest that following primary infection either CD4+ or CD8+ T cells alone may be sufficient to control a secondary challenge.



View larger version (15K):
[in this window]
[in a new window]
 
FIGURE 2. The role of MHC class I- and class II-restricted T cells in secondary immunity to HC. MHC class II-/- or {beta}2m-/- mice were infected with a sublethal dose (6 x 104) of HC and reinfected with a lethal dose (6 x 105) of HC 3 wk later. Mice were followed for mortality as described above. The data were combined from three experiments.

 
Perforin has an essential role in primary immunity following sublethal infection with HC

Immune effector mechanisms by which CD4+ and CD8+ T cells could exert control of HC are through the production of cytokines such as IFN-{gamma} and TNF-{alpha} and/or through a cytolytic mechanism. Because we were interested in exploring noncytokine-dependent pathways for immunity, the role of perforin in immunity to HC infection was assessed using PfKO mice. As shown in Fig. 3GoA, in data combined from three independent experiments, PfKO mice infected with a lethal dose of HC (6 x 105) had accelerated mortality (13.5 ± 2.1 days) and increased fungal burden at both 7 and 14 days postinfection compared with wild-type mice (18.1 ± 3.6 days) (p < 0.01). Remarkably, all the PfKO mice succumbed, even following a sublethal (6 x 104) primary challenge (27.6 ± 1.8 days), which again correlated with increased fungal burden compared with the control mice (p < 0.001). Thus, in addition to the essential role for cytokines, these surprising data highlight a critical role for perforin in mediating primary immunity to HC. Finally, the role of perforin in secondary immunity was also assessed. For these experiments, mice were initially infected with a very low dose of HC (1 x 104) and then rechallenged with a lethal dose 3 wk later. As shown in Fig. 3GoB, perforin was not required for protective immunity following secondary challenge with a normally lethal dose of HC. However, it should be noted that PfKO mice did have an ~4-fold increase in fungal burden when assessed 14 days postreinfection compared with C57BL/6 mice. Together, these data are consistent with our previous reports showing that many of the factors (e.g., cytokines, neutrophils, NO) required for primary immunity may not be essential to mediate protection following secondary challenge (7).



View larger version (24K):
[in this window]
[in a new window]
 
FIGURE 3. Perforin has an essential role in primary but not secondary immunity to HC infection. A, PfKO mice or normal C57BL/6 mice (n = 10 per group) were infected i.v. with a lethal (6 x 105) or sublethal (6 x 104) dose of HC and the rate of mortality followed. The data were combined from three experiments. The fungal burden of HC was quantitated from three individual spleens of PfKO or normal mice following infection with HC at various time points postinfection. *, The amount of HC from spleens of PfKO mice was significantly greater (p < 0.001) than that from spleens of mice infected with HC alone following either a lethal or sublethal challenge. B, PfKO mice and C57BL/6 mice were initially infected i.v. with 1 x 104 yeast cells, and groups of mice (n = 6) were reinfected i.v. 3 wk later with 6 x 105 yeast cells. The mortality rate was monitored postinfection. The amount of HC from spleen cells of infected PfKO and wild-type mice was assessed as described above. These data are from one of three independent experiments with similar results.

 
CD8+ T cells have a role in primary immunity that is independent of perforin

The findings in the previous figures showing that both CD8+ T cells and perforin have critical roles in mediating protective immunity in primary infection to HC raise the question of whether CD8+ T cells are mediating their effect exclusively through perforin and/or through the production of cytokines such as IFN-{gamma} and TNF-{alpha}. To further delineate the respective roles for the aforementioned factors, PfKO mice were depleted of CD8+ T cells at the time of infection. In addition, PfKO mice were treated with Abs against IFN-{gamma} or TNF-{alpha} at the time of infection to assess the role of cytokines in the absence of a major cytolytic mechanism. Similar to the results shown above, PfKO mice had accelerated mortality (15.0 ± 1.5 days) compared with wild-type mice (21.8 ± 2.9 days) (p < 0.001) (Fig. 4GoA). In addition, PfKO mice depleted of CD8+ T cells succumbed even earlier to infection (10.0 ± 0.4 days) compared with PfKO mice not depleted of CD8+ T cells. These latter data suggest that CD8+ T cells have a role in primary immunity independent of perforin. Furthermore, PfKO mice depleted of IFN-{gamma} (Fig. 4GoA) (8.8 ± 1.0 days) or TNF-{alpha} (Fig. 4GoB) (7.5 ± 0.6 days) had accelerated mortality when compared with noncytokine-depleted PfKO mice (p < 0.001). These latter data suggest that both IFN-{gamma} and TNF-{alpha} have a role in mediating immunity in the absence of perforin. As a biologic correlate to the mortality data, the fungal burden was assessed from spleen cells of all the groups at 7 and 15 days postinfection. Depletion of CD8+ T cells caused a 2- to 3-fold increase in fungal burden from spleen cells of PfKO mice when compared with the CFU obtained from non-CD8+ T cell-depleted PfKO mice (p < 0.001) (Table IGo). Furthermore, depletion of IFN-{gamma} or TNF-{alpha} in PfKO mice caused ~5- and ~17-fold increases in the amount of HC, respectively, compared with PfKO mice. Thus, primary protection against HC appears to be mediated through a variety of pathways that includes CD8+ T cells, perforin, IFN-{gamma}, and TNF-{alpha}.



View larger version (25K):
[in this window]
[in a new window]
 
FIGURE 4. Mechanisms of perforin-independent immunity to primary HC infection. A, PfKO and wild-type C57BL/6 mice (n = 6 mice each) were injected i.v. with a lethal dose (6 x 105) of yeast cells (HC). Some groups of mice were also treated i.p. with anti-IFN-{gamma} at the time of infection or anti-CD8 Ab 3 days before, at the time of, and 3 days postinfection. Mortality was monitored postinfection. Data are combined from two independent experiments. B, PfKO mice and wild-type C57BL/6 mice (n = 4 mice each) were injected i.v. with a lethal dose of HC (6 x 105) yeast cells. Some groups of mice were also treated i.p. with anti-TNF-{alpha} at the time of infection. Mortality was monitored postinfection. Data are combined from two independent experiments.

 

View this table:
[in this window]
[in a new window]
 
Table I. Fungal burden in PfKO or normal mice at days 7 and 15 postinfection1

 
CD8+ T cells from infected PfKO mice can mediate immunity to HC in IFN-{gamma}-/- mice

The previous findings that depletion of CD8+ T cells in PfKO mice causes increased fungal burden and accelerated mortality suggest that production of IFN-{gamma} and/or TNF-{alpha} by CD8+ T cells may mediate control of infection. To directly determine whether CD8+ T cells from PfKO mice have effector function in vivo, highly purified CD8+ cells from previously infected PfKO and wild-type C57BL/6 mice were adoptively transferred into IFN-{gamma}-/- mice. These mice were then challenged with HC. As shown in Fig. 5Go, IFN-{gamma}-/- mice succumbed (10.4 ± 0.5 days) to a sublethal infection with HC. Adoptive transfer of CD8+ T cells isolated from infected PfKO mice resulted in enhanced survival (17.3 ± 1.8 days) (p < 0.001) and reduced fungal burden (~4-fold decrease) compared with the control-infected IFN-{gamma}-/- mice (p < 0.001). Moreover, adoptive transfer of CD8+ T cells from wild-type C57BL/6 mice resulted in longer survival (23.8 ± 2.7 days) (p < 0.001) and a more striking decrease (~20-fold) in fungal burden compared with that of mice receiving CD8+ T cells from PfKO mice (p < 0.001). These data provide clear evidence that CD8+ T cells from PfKO mice can have effector function in vivo, as assessed by survival and reduction in fungal burden. Moreover, this effector function could be mediated by IFN-{gamma}.



View larger version (19K):
[in this window]
[in a new window]
 
FIGURE 5. CD8+ T cells from PfKO mice can mediate immunity to HC infection in IFN-{gamma}-/- mice. Naive IFN-{gamma}-/- mice (n = 8 mice/group) were injected i.v. with 3 x 106 CD8+ T cells isolated from infected PfKO or C57BL/6 mice. On the same day as the adoptive transfer of CD8+ T cells, mice were infected i.v. with 3 x 104 HC yeast cells. As a positive control, naive IFN-{gamma}-/- mice not receiving CD8+ T cells were also infected with 3 x 104 HC yeast cells. The mortality of all the groups was monitored postinfection. The fungal burden of HC was quantitated from the spleen cells of all groups of mice at day 10 postinfection. *, Significantly different (p < 0.001) compared with IFN-{gamma}-/- mice infected with HC alone. {wedge}, Significantly different (p < 0.001) compared with IFN-{gamma}-/- mice treated with CD8+ T cells from PfKO mice.

 
PfKO mice have diminished NK cell cytolytic activity

Because perforin is present in both CD8+ T cells and NK cells, it was of interest to determine whether CD8+ or NK cells from PfKO mice could mediate any killing of target cells in vitro. To date, we have not been successful in developing an assay for CD8+ CTL activity in vitro; however, we were able to assess NK cytolytic activity using YAC-1 cells as targets. As shown in Fig. 6GoA, lysis of YAC-1 cells by total spleen cells from C57BL/6 mice was substantially enhanced from infected spleen cells of C57BL/6 but not PfKO mice when assessed 3 days postinfection. Similar data were seen in a separate experiment (Fig. 6GoB). Moreover, in this same experiment, there was essentially no cytolytic activity detected from either infected C57BL/6 or PfKO mice when assessed 6 days postinfection (Fig. 6GoC). Thus, these data suggest that early NK cytolytic activity mediated by perforin (15, 16) may be important in the initial control of fungal growth.



View larger version (17K):
[in this window]
[in a new window]
 
FIGURE 6. PfKO mice have diminished NK cell cytolytic activity. PfKO and C57BL/6 mice were infected with a lethal dose (6 x 105) of HC yeast cells. A, Total spleen cells from three individual C57BL/6 or PfKO mice were harvested at day 3 postinfection and used in a 4-h 51Cr release cytotoxicity assay as described in Materials and Methods. As a control, total spleen cells from uninfected C57BL/6 and PfKO mice were used in parallel. In a separate experiment, spleen cells were harvested 3 (B) and 6 (C) days postinfection from C57BL/6 and PfKO mice. Similar uninfected cells from C57BL/6 and PfKO mice were used as controls.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Lymphocyte-mediated cytotoxicity plays an important role in immune protection and surveillance against intracellular infections and tumors. In this regard, there is a variety of mechanisms by which lymphocytes mediate their cytolytic activity (15). For cytotoxic T cells, there appear to be at least two well-defined mechanisms. The first pathway involves secretion of perforin by cytotoxic cells, and the second involves the interaction of Fas ligand and Fas receptor on the effector and target cell, respectively. In this report, we show that perforin is essential for protective immunity following infectious challenge with the fungus HC. Moreover, these data, in conjunction with previous work by us (7) and others (8), further establish the multifactorial nature of how cytokines such as IFN-{gamma} and TNF-{alpha} work in concert with cytolytic mechanisms (i.e., perforin) to provide protective immunity against primary infection by a pathogenic fungus.

The role of perforin in primary and secondary immunity to HC

The most striking finding of our studies reported here is the importance of perforin in mediating primary immunity to HC. The importance of perforin was highlighted by the observation that PfKO mice readily succumbed in response to a sublethal infection. With regard to the role of perforin in immune protection against other infections, previous work has demonstrated that perforin is essential for protection against certain viral (16, 17) and bacterial (18) infections. By contrast, although perforin appears to have some role in immunity against other intracellular infections such as Mycobacterium tuberculosis (19) and Toxoplasma gondii (20), it is not essential for protective immunity. Thus, because there is a commonality in the requirement for type 1 immune responses for protective immunity against M. tuberculosis, T. gondii, and HC, the requirement for perforin in primary HC infection is unique. Once primary immunity is established against HC, perforin does not appear to be required to sustain protection following secondary challenge.

There are several mechanisms by which perforin could mediate its effects in HC infection. First would be a direct role in which perforin released by CD8+ T cells causes lysis of an infected target cell. It is also possible that perforin from NK cells has a similar direct role in mediating intracellular killing early in infection. As noted in Fig. 6Go, there was essentially no lysis of YAC-1 target cells in vitro using spleen cells from PfKO mice following infection. By contrast, lysis of YAC-1 cells was detected from spleen cells of wild-type mice at 3 days but not at 6 days postinfection. These data suggest that if NK cell cytolysis is important in immunity against HC, it would likely be early after infection and be mediated by perforin (15).

Perforin-dependent and -independent pathways of immunity to HC

As noted above, there are at least two major pathways by which intracellular infections are eliminated. One pathway is via cytokines such as IFN-{gamma} and TNF-{alpha}, and the other is through a direct cytolytic pathway by perforin- or Fas-mediated lysis. In this regard, there has been a substantial amount of work in delineating the respective roles of cytokines and cytolytic mechanisms in the Listeria mouse model of infection. In this model, initial studies showed that in adoptive transfer experiments, protective immunity by CD8+ T cells from PfKO mice was substantially less than from wild-type mice following Listeria challenge (18). These data established an important role for perforin in this infection. Interestingly, in a subsequent study by Harty and Bevan, CD8+ T cell immunity against L. monocytogenes could be sustained in the absence of IFN-{gamma} (14). Moreover, these data were substantiated in a separate report showing that CD8+ but not CD4+ T cells from IFN-{gamma}-deficient mice could clear chronic infection when transferred into SCID mice (21). Together, these data clearly established a CD8+ T cell-dependent, IFN-{gamma}-independent mechanism for protection against Listeria. Several additional studies showed that in the absence of both perforin and IFN-{gamma}, TNF-{alpha} had a critical role in mediating immunity in the spleen following infection (22, 23).

In the studies reported here, it was of interest that depletion of CD8+ T cells in infected PfKO mice resulted in increased fungal burden and accelerated mortality when compared with infected PfKO mice only. These data suggest that CD8+ T cells could mediate some immunity against HC in the absence of perforin. Furthermore, CD8+ T cells from PfKO mice did provide some immunity when adoptively transferred into IFN-{gamma}-/- mice. Thus, these data suggest that there is a perforin-independent mechanism of immunity that is likely due to low levels of IFN-{gamma} and/or TNF-{alpha}.

A model for mechanisms regulating primary and secondary immunity to disseminated histoplasmosis

Based on previous data in addition to those reported here, the factors necessary for primary immunity to pulmonary or systemic HC infection require a coordinated response mediated by a multitude of factors. By contrast, for secondary immunity to HC there is redundancy in the requirements for protection such that immunity can be sustained in the absence of factors required for primary infection. With regard to the role of T cells in primary immunity, it is clear that CD4+ T cells are essential for primary immunity to HC infection. Furthermore, depletion of CD4+ T cells is correlated with a marked reduction in production of IFN-{gamma} (8). Thus, CD4+ T cell production of IFN-{gamma} appears to be the major mechanism by which they mediate their effect. For secondary infection, CD4+ T cells are not required for protective immunity; however, in a study in which mice were treated with a drug to control primary infection, IFN-{gamma}-/- mice were shown to survive and clear infection following a secondary lethal challenge (7). Furthermore, depletion of CD4+ T cells or TNF-{alpha} in these mice caused accelerated mortality and a striking increase in fungal burden. Thus, these data are consistent with a critical role for TNF-{alpha} in secondary infection that is independent of IFN-{gamma} (7, 24) and suggest that CD4+ T cells may be a source for this TNF-{alpha}, or may be required to initiate TNF-{alpha} expression by some other cell type. CD8+ T cells also appear to have an important role in controlling fungal growth in primary immunity against HC. As shown here, one mechanism by which CD8+ T cells mediate their effect is through perforin. Moreover, in the absence of perforin, we show here that CD8+ T cells do have an effector role in primary infection that is likely mediated through IFN-{gamma} and/or TNF-{alpha}. For secondary immunity, CD8+ T cells or perforin are not required. Our previous data showed that in the absence of IFN-{gamma}, depletion of CD8+ T cells resulted in accelerated mortality following secondary infection. These data suggest that perforin or TNF-{alpha} from CD8+ T cells may have a role in secondary immunity in the absence of IFN-{gamma}-/-, which is similar to data obtained in the Listeria mouse model (25). Overall, these data extend previous work in elucidating the cellular mechanisms by which immunity is achieved following infection by HC.


    Acknowledgments
 
We thank Jane Hu-Li for technical assistance and Nancy Shulman and Brenda Rae Marshall for editorial assistance.


    Footnotes
 
1 Address correspondence and reprint requests to Dr. Robert A. Seder, Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 10 Center Drive, Room 10/11C215, Bethesda, MD 20892. Back

2 Abbreviations used in this paper: HC, Histoplasma capsulatum; {beta}2m, {beta}2-microglobulin; PfKO, perforin-deficient knockout; BHI, brain-heart infusion; YAC, yeast artificial chromosome. Back

Received for publication August 2, 2000. Accepted for publication November 13, 2000.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Wheat, L. J., P. A. Connolly-Stringfield, R. L. Baker, M. F. Curfman, M. E. Eads, K. S. Israel, S. A. Norris, D. H. Webb, M. L. Zeckel. 1990. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine 69:361.[Medline]
  2. Johnson, P. C., N. Khardori, A. F. Najjar, F. Butt, P. W. Mansell, G. A. Sarosi. 1988. Progressive disseminated histoplasmosis in patients with acquired immunodeficiency syndrome. Am. J. Med. 85:152.[Medline]
  3. Tripp, C. S., M. K. Gately, J. Hakimi, P. Ling, E. R. Unanue. 1994. Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice: reversal by IFN-{gamma}. J. Immunol. 152:1883.[Abstract]
  4. Zhou, P., M. C. Sieve, J. Bennett, K. J. Kwon-Chung, R. P. Tewari, R. T. Gazzinelli, A. Sher, R. A. Seder. 1995. IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-{gamma}. J. Immunol. 155:785.[Abstract]
  5. Allendoerfer, R., G. P. Boivin, Jr G. S. Deepe. 1997. Modulation of immune responses in murine pulmonary histoplasmosis. J. Infect. Dis. 175:905.[Medline]
  6. Heinzel, F. P., D. S. Schoenhaut, R. M. Rerko, L. E. Rosser, M. K. Gately. 1993. Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177:1505.[Abstract/Free Full Text]
  7. Zhou, P., G. Miller, R. A. Seder. 1998. Factors involved in regulating primary and secondary immunity to infection with Histoplasma capsulatum: TNF-{alpha} plays a critical role in maintaining secondary immunity in the absence of IFN-{gamma}. J. Immunol. 160:1359.[Abstract/Free Full Text]
  8. Allendoerfer, R., G. D. Brunner, Jr G. S. Deepe. 1999. Complex requirements for nascent and memory immunity in pulmonary histoplasmosis. J. Immunol. 162:7389.[Abstract/Free Full Text]
  9. Williams, D. M., J. R. Graybill, D. J. Drutz. 1978. Histoplasma capsulatum infection in nude mice. Infect. Immun. 21:973.[Abstract/Free Full Text]
  10. Zhou, P., M. C. Sieve, R. P. Tewari, R. A. Seder. 1997. Interleukin-12 modulates the protective immune response in SCID mice infected with Histoplasma capsulatum. Infect. Immun. 65:936.[Abstract]
  11. Gomez, A. M., W. E. Bullock, C. L. Taylor, Jr G. S. Deepe. 1988. Role of L3T4+ T cells in host defense against Histoplasma capsulatum. Infect. Immun. 56:1685.[Abstract/Free Full Text]
  12. Jr Deepe, G. S.. 1994. Role of CD8+ T cells in host resistance to systemic infection with Histoplasma capsulatum in mice. J. Immunol. 152:3491.[Abstract]
  13. Scharton-Kersten, T. M., T. A. Wynn, E. Y. Denkers, S. Bala, E. Grunvald, S. Hieny, R. T. Gazzinelli, A. Sher. 1996. In the absence of endogenous IFN-{gamma}, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J. Immunol. 157:4045.[Abstract]
  14. Harty, J. T., M. J. Bevan. 1995. Specific immunity to Listeria monocytogenes in the absence of IFN-{gamma}. Immunity 3:109.[Medline]
  15. Kagi, D., B. Ledermann, K. Burki, R. M. Zinkernagel, H. Hengartner. 1996. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 14:207.[Medline]
  16. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31.[Medline]
  17. Walsh, C. M., M. Matloubian, C. C. Liu, R. Ueda, C. G. Kurahara, J. L. Christensen, M. T. Huang, J. D. Young, R. Ahmed, W. R. Clark. 1994. Immune function in mice lacking the perforin gene. Proc. Natl. Acad. Sci. USA 91:10854.[Abstract/Free Full Text]
  18. Kagi, D., B. Ledermann, K. Burki, H. Hengartner, R. M. Zinkernagel. 1994. CD8+ T cell-mediated protection against an intracellular bacterium by perforin-dependent cytotoxicity. Eur. J. Immunol. 24:3068.[Medline]
  19. Cooper, A. M., C. D’Souza, A. A. Frank, I. M. Orme. 1997. The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perforin- or granzyme-mediated cytolytic mechanisms. Infect. Immun. 65:1317.[Abstract]
  20. Denkers, E. Y., G. Yap, T. Scharton-Kersten, H. Charest, B. A. Butcher, P. Caspar, S. Heiny, A. Sher. 1997. Perforin-mediated cytolysis plays a limited role in host resistance to Toxoplasma gondii. J. Immunol. 159:1903.[Abstract]
  21. Bhardwaj, V., O. Kanagawa, P. E. Swanson, E. R. Unanue. 1998. Chronic Listeria infection in SCID mice: requirements for the carrier state and the dual role of T cells in transferring protection or suppression. J. Immunol. 160:376.[Abstract/Free Full Text]
  22. White, D. W., J. T. Harty. 1998. Perforin-deficient CD8+ T cells provide immunity to Listeria monocytogenes by a mechanism that is independent of CD95 and IFN-{gamma} but requires TNF-{alpha}. J. Immunol. 160:898.[Abstract/Free Full Text]
  23. Badovinac, V. P., J. T. Harty. 2000. Adaptive immunity and enhanced CD8+ T cell response to Listeria monocytogenes in the absence of perforin and IFN-{gamma}. J. Immunol. 164:6444.[Abstract/Free Full Text]
  24. Samsom, J. N., J. A. Langermans, H. F. Savelkoul, R. van Furth. 1995. Tumour necrosis factor, but not interferon-{gamma}, is essential for acquired resistance to Listeria monocytogenes during a secondary infection in mice. Immunology 86:256.[Medline]
  25. White, D. W., V. P. Badovinac, G. Kollias, J. T. Harty. 2000. Antilisterial activity of CD8+ T cells derived from TNF-deficient and TNF/perforin double-deficient mice. J. Immunol. 165:5.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J. Immunol.Home page
G. S. Deepe Jr. and R. S. Gibbons
TNF-{alpha} Antagonism Generates a Population of Antigen-Specific CD4+CD25+ T Cells That Inhibit Protective Immunity in Murine Histoplasmosis
J. Immunol., January 15, 2008; 180(2): 1088 - 1097.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. C. D. Wiseman, L. L. Ma, K. J. Marr, G. J. Jones, and C. H. Mody
Perforin-Dependent Cryptococcal Microbicidal Activity in NK Cells Requires PI3K-Dependent ERK1/2 Signaling
J. Immunol., May 15, 2007; 178(10): 6456 - 6464.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. M. Lindell, T. A. Moore, R. A. McDonald, G. B. Toews, and G. B. Huffnagle
Generation of Antifungal Effector CD8+ T Cells in the Absence of CD4+ T Cells during Cryptococcus neoformans Infection
J. Immunol., June 15, 2005; 174(12): 7920 - 7928.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
J.-S. Lin and B. A. Wu-Hsieh
Functional T cells in primary immune response to histoplasmosis
Int. Immunol., November 1, 2004; 16(11): 1663 - 1673.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M. Wuthrich, H. I. Filutowicz, T. Warner, G. S. Deepe Jr., and B. S. Klein
Vaccine Immunity to Pathogenic Fungi Overcomes the Requirement for CD4 Help in Exogenous Antigen Presentation to CD8+ T Cells: Implications for Vaccine Development in Immune-deficient Hosts
J. Exp. Med., June 2, 2003; 197(11): 1405 - 1416.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhou, P.
Right arrow Articles by Seder, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhou, P.
Right arrow Articles by Seder, R. A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS